Philadelphia gene therapy developer Passage Bio names former Novartis executive as new CEO


The new CEO had a key role in the commercial launch of a cancer-fighting cell therapy developed by Penn researchers.

Previous Funding wrap: Tens of millions of dollars secured for M&A, business lending
Next Thrive Restaurant Group taps Kansas City for bigger opportunity